ÂÜÀòÂÒÂ×

Keith Cheah is a Data Scientist at BigHat Biosciences, bringing a robust background in machine learning and oncology research from experiences at the Massachusetts Institute of Technology (MIT). During a tenure as a Graduate Researcher at MIT, Keith developed predictive tools for prostate cancer metastasis risk and led projects in protein engineering aimed at cancer therapy development. Keith's leadership skills are exemplified by a role as Director of Industry for the MIT Biotech Group, where extensive educational and networking events were organized. Additional experiences include consulting roles in energy strategy at Emirates Global Aluminium and market entry strategies for Shell's EV initiatives. Academically, Keith holds a PhD and M.S. in Chemical Engineering from MIT, complemented by a Healthcare Certificate from MIT Sloan School of Management and a M.Eng. in Chemical Engineering from Imperial College London.